- Home
- MDGL vs TPG Comparison
MDGL vs TPG Comparison
Compare MDGL & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDGL | TPG |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 7.0B |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MDGL | TPG |
|---|---|---|
| Price | $534.49 | $47.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | ★ $674.45 | $61.20 |
| AVG Volume (30 Days) | 214.6K | ★ 2.8M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.89% |
| EPS Growth | N/A | ★ 207.14 |
| EPS | N/A | ★ 0.17 |
| Revenue | $180,133,000.00 | ★ $4,670,212,000.00 |
| Revenue This Year | $58.39 | N/A |
| Revenue Next Year | $48.55 | $19.79 |
| P/E Ratio | ★ N/A | $287.71 |
| Revenue Growth | N/A | ★ 33.43 |
| 52 Week Low | $393.61 | $36.95 |
| 52 Week High | $615.00 | $70.38 |
Technical Indicators
Market Signals| Indicator | MDGL | TPG |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 37.36 |
| Support Level | $499.26 | $41.26 |
| Resistance Level | $545.13 | $55.20 |
| Average True Range (ATR) | 17.53 | 1.60 |
| MACD | 0.24 | -0.92 |
| Stochastic Oscillator | 43.24 | 2.58 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms, namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, market solutions, innovation, and inclusion.